{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T03:09:24Z","timestamp":1714705764957},"reference-count":33,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatric Ment Health Nurs"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:p>Medication continues to be the most widely prescribed treatment in the NHS for mental health problems. It has been known for many years that individuals differ in the way they respond to a given pharmaceutical therapy, and one reason for this lies in the genetic variation between individuals. This paper recognizes the impact that pharmacogenomics and pharmacogenetics are having in the field of mental health. Variants in genes that code for the drug metabolizing enzymes in the liver have been found to influence the way in which these enzymes handle psychotropic medication. Individuals can be classified as poor, moderate or extensive metabolizers when standard regimes are used, and this can lead to huge differences in therapeutic effect and toxicity. There are now genotyping tests available which provide information on the individual's ability to metabolize psychotropic medication. One author provides an account of the effects of medication on her son's physical and psychological well\u2010being. Genotyping provided evidence for his poor metabolism of psychotropic medication, and his life is now changing as he is being very gradually weaned off this medication. This emerging field of work has implications for the way in which practitioners consider medication adherence.<\/jats:p>","DOI":"10.1111\/j.1365-2850.2007.01234.x","type":"journal-article","created":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T11:24:16Z","timestamp":1209641056000},"page":"357-364","source":"Crossref","is-referenced-by-count":11,"title":["Should we be \u2018pushing meds\u2019? The implications of pharmacogenomics"],"prefix":"10.1111","volume":"15","author":[{"given":"J.","family":"BRAY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"CLARKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"BRENNAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"MUNCEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,5]]},"reference":[{"key":"e_1_2_6_2_1","volume-title":"Avoidable Deaths","author":"Appleby L.","year":"2006"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","unstructured":"Arehart\u2010TreichelJ.(2006)Gene testing could help predict drug response. Available at:http:\/\/pn.psychiatryonline.org\/cgi\/content\/full\/40\/10\/33(accessed 13 December 2006).","DOI":"10.1176\/pn.40.10.00400033"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e328017f69f"},{"key":"e_1_2_6_5_1","volume-title":"A Scoping Review of Evaluated Psychological Interventions Training National Institute for Mental Health, Department of Health, Crown Copyright","author":"Brooker C.","year":"2005"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200002000-00024"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0103"},{"key":"e_1_2_6_8_1","unstructured":"GillmanK.(2006)Cytochrome P450 enzymes\u2010introduction. Available at:http:\/\/www.psychotropical.com\/Cytochrome_P450_enzymes_Introduction.shtml(accessed 13 December 2006)."},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.105.019489"},{"key":"e_1_2_6_10_1","volume-title":"Talking About Medicines: The Management of Medicines in Trusts Providing Mental Health Services","author":"Healthcare Commission","year":"2007"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198809000-00009"},{"key":"e_1_2_6_12_1","first-page":"792","article-title":"Pharmacodynamics and drug therapy","volume":"10","author":"Kelly J.","year":"1995","journal-title":"Professional Nurse"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.7748\/mhp2006.09.10.1.15.c4285"},{"key":"e_1_2_6_14_1","first-page":"8","article-title":"Metabolic changes associated with antipsychotic use","volume":"6","author":"Lieberman J.A.","year":"2004","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721020-00005"},{"key":"e_1_2_6_16_1","volume-title":"Realising the Potential of Genomic Medicine","author":"Martin P.","year":"2006"},{"key":"e_1_2_6_17_1","volume-title":"Evidence Report\/Technology Assessment Number 146 Testing for Cytochrome P450 Polymorphisms in Adults with Non\u2010psychotic Depression Treated with Selective Serotonin Reuptake Inhibitors (SSRI'S)","author":"Matchar D.","year":"2006"},{"key":"e_1_2_6_18_1","volume-title":"Pharmacogenomics: A New Opportunity for Pharmacists","author":"Moffat T.","year":"2001"},{"key":"e_1_2_6_19_1","volume-title":"Is Psychiatry for Sale?","author":"Moncrieff J.","year":"2003"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2006.00787.x"},{"key":"e_1_2_6_21_1","volume-title":"Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia.","author":"National Institute for Clinical Excellence","year":"2002"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.49.9.1163"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","unstructured":"PoirierJ. DelisleM.C. QuirionR. et\u2003al.(1995)Apolipoprotein E4 Allele as a Predictor of Cholinergic Deficits and Treatment Outcome in Alzheimer Disease.Proceedings of the National Academy of Sciences of the United States of America Vol. 92 No. 26 (December 19 1995) pp.12260\u201312264.","DOI":"10.1073\/pnas.92.26.12260"},{"key":"e_1_2_6_24_1","volume-title":"Pre\u2010therapy Reaching Contact Impaired Clients.","author":"Prouty G.","year":"2002"},{"key":"e_1_2_6_25_1","volume-title":"Coping with Coming off.","author":"Read J.","year":"2005"},{"key":"e_1_2_6_26_1","unstructured":"Royal College of Psychiatrists(2006)Consensus statement on high\u2010dose antipsychotic medication.Available at:http:\/\/www.psychminded.co.uk\/news\/news2006\/may06\/concensusstatementonhighdoseantipsychotics.pdf(accessed 1 July 2007)."},{"key":"e_1_2_6_27_1","first-page":"22","article-title":"Pharmacokinetics, metabolism, and drug\u2013drug interactions of atypical antipsychotics in special populations","volume":"5","author":"Sharif Z.","year":"2003","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"key":"e_1_2_6_28_1","volume-title":"Essential Psychopharmacology","author":"Stahl S.","year":"2000"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-001-0967-0"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.06.011"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119801200412"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2850.2006.01026.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-9877(03)00293-7"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.2165\/00129785-200303060-00004"}],"container-title":["Journal of Psychiatric and Mental Health Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2850.2007.01234.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2850.2007.01234.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T10:20:40Z","timestamp":1697365240000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2850.2007.01234.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1365-2850.2007.01234.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2850.2007.01234.x","archive":["Portico"],"relation":{},"ISSN":["1351-0126","1365-2850"],"issn-type":[{"value":"1351-0126","type":"print"},{"value":"1365-2850","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}